The Direct Effects of Fingolimod in the Central Nervous System: Implications for Relapsing Multiple Sclerosis
Crossref DOI link: https://doi.org/10.1007/s40263-015-0297-0
Published Online: 2015-12-29
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hunter, Samuel F.
Bowen, James D.
Reder, Anthony T.
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation (US)
License valid from 2015-12-29